naltrexone has been researched along with fingolimod hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mihalova, T; Salam, S; Siripurapu, R | 1 |
| Kang, Y; Kim, JH; Lee, PR; Oh, SB; Vang, H; Won, J | 1 |
2 other study(ies) available for naltrexone and fingolimod hydrochloride
| Article | Year |
|---|---|
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Topics: Adult; Brain; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Naltrexone; Narcotic Antagonists; Recurrence; Withholding Treatment | 2016 |
TRPM7 Mediates Mechanosensitivity in Adult Rat Odontoblasts.
Topics: Animals; Fingolimod Hydrochloride; Gadolinium; Immunohistochemistry; Ionomycin; Male; Mechanotransduction, Cellular; Naltrexone; Odontoblasts; Radiometry; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Thapsigargin; Transient Receptor Potential Channels; TRPM Cation Channels | 2018 |